Literature DB >> 26241549

Inhibitory effect of group II mGluR agonist 2R, 4R-APDC on cell proliferation in dentate gyrus in rats with epileptic seizure.

H Yao1, Y-B Feng, Y-J Pang, J-J Xu, B-X Yu, X-P Liu.   

Abstract

OBJECTIVE: Epileptic seizure can increase the cell proliferation in dentate gyrus in brain, but the mechanism remains unclear.
MATERIALS AND METHODS: In this study, using systemic bromodeoxyuridine (BrdU) to label the dividing cells, the inhibitory effect of group II metabotropic glutamate receptor (mGluR) agonist 2R, 4R-4-aminopyrrolidine-2, 4-dicarboxylate (2R, 4R-APDC) on cell proliferation in dentate gyrus in rats after pilocarpine-induced status epilepticus (SE) was investigated.
RESULTS: Results found that, 2R, 4R-APDC could significantly inhibit the behavioral seizure and block the seizure-induced increase of BrdU-positive cells in dentate gyrus, especially in hilus. Double-label immunofluorescence staining showed that, 2R, 4R-APDC did not affect the ability of newborn cells to differentiate into neurons or astrocytes.
CONCLUSIONS: 2R, 4R-APDC not only has anticonvulsant effect on adult rats with pilocarpine-induced SE, but also has neuroprotective effect by reducing the abnormal regeneration of nerves.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26241549

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  2R,4R-APDC, a Metabotropic Glutamate Receptor Agonist, Reduced Neuronal Apoptosis by Upregulating MicroRNA-128 in a Rat Model After Seizures.

Authors:  Ya-Bo Feng; You-Ting Lin; Yu-Xiang Han; Yue-Jiu Pang; Jing-Jing Xu; Yuan Xue; Hong Yao
Journal:  Neurochem Res       Date:  2018-03-01       Impact factor: 3.996

2.  Metabotropic glutamate receptor: A new possible therapeutic target for cochlear synaptopathy.

Authors:  Parvane Mahdi; Akram Pourbakht; Alireza Karimi Yazdi; Mahtab Rabbani Anari; Vahid Pirhajati Mahabadi; Mohammad Kamali
Journal:  Iran J Basic Med Sci       Date:  2022-01       Impact factor: 2.532

Review 3.  N-Acetyl-Aspartyl-Glutamate in Brain Health and Disease.

Authors:  Cecilie Morland; Kaja Nordengen
Journal:  Int J Mol Sci       Date:  2022-01-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.